Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V P Chulanov

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Terapevticheskii Arkhiv|May 11, 2023
[Pharmacoeconomic evaluation of the tixagevimab and cilgavimab combination using for pre-exposure prophylaxis of COVID-19]M V Zhuravleva, V P Chulanov, J V Gagarina, et al.
Terapevticheskii Arkhiv|April 1, 2016
[Resistance to protease inhibitors and efficiency of antiviral therapy in patients with chronic hepatitis C]S N Batskikh, I V Karandashova, A D Neverov, et al.
Terapevticheskii Arkhiv|December 21, 2012
[Hepatitis C virus genotype 3: that simple, yet that complex (corrected)]S N Batskikh, S V Morozov, V P Chulanov, et al.
Terapevticheskii Arkhiv|December 28, 2024
[Infant botulism: an underestimated problem. A review]V A Malov, V V Maleev, V P Chulanov, et al.
Terapevticheskii Arkhiv|January 8, 2004
[Characteristics of cellular immunity in children with acute viral hepatitis A]N A Budarina, O F Belaia, V P Chulanov, et al.
Terapevticheskii Arkhiv|December 21, 2012
[Long-term entecavir efficacy retention in the treatment of chronic hepatitis B with an outcome to hepatic cirrhosis caused by its resistant virus strain]O O Znoiko, K R Dudina, N Kh Safiullina, et al.
Klinicheskaia Laboratornaia Diagnostika|October 14, 2000
[Algorithm for specific laboratory diagnosis in viral hepatitis among inpatients (lecture)]I A Simonova, E V Volchkova, V P Chulanov, et al.
Terapevticheskii Arkhiv|December 21, 2017
[Hepatitis C can be cured: will hepatitis B become next?]V P Chulanov, A P Zueva, D S Kostyushev, et al.
Terapevticheskii Arkhiv|January 18, 2014
[The relevance and prospects of introducing a uniform federal register of patients with viral hepatitis B and C in Russia]N N Pimenov, A V Vdovin, S V Komarova, et al.
Terapevticheskii Arkhiv|January 30, 2016
[Chronic hepatitis C in Russia: current challenges and prospects]V P Chulanov, N N Pimenov, N A Mamonova, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Terapevticheskii Arkhiv|May 11, 2023
[Pharmacoeconomic evaluation of the tixagevimab and cilgavimab combination using for pre-exposure prophylaxis of COVID-19]M V Zhuravleva, V P Chulanov, J V Gagarina, et al.
Terapevticheskii Arkhiv|April 1, 2016
[Resistance to protease inhibitors and efficiency of antiviral therapy in patients with chronic hepatitis C]S N Batskikh, I V Karandashova, A D Neverov, et al.
Terapevticheskii Arkhiv|December 21, 2012
[Hepatitis C virus genotype 3: that simple, yet that complex (corrected)]S N Batskikh, S V Morozov, V P Chulanov, et al.
Terapevticheskii Arkhiv|December 28, 2024
[Infant botulism: an underestimated problem. A review]V A Malov, V V Maleev, V P Chulanov, et al.
Terapevticheskii Arkhiv|January 8, 2004
[Characteristics of cellular immunity in children with acute viral hepatitis A]N A Budarina, O F Belaia, V P Chulanov, et al.
Terapevticheskii Arkhiv|December 21, 2012
[Long-term entecavir efficacy retention in the treatment of chronic hepatitis B with an outcome to hepatic cirrhosis caused by its resistant virus strain]O O Znoiko, K R Dudina, N Kh Safiullina, et al.
Klinicheskaia Laboratornaia Diagnostika|October 14, 2000
[Algorithm for specific laboratory diagnosis in viral hepatitis among inpatients (lecture)]I A Simonova, E V Volchkova, V P Chulanov, et al.
Terapevticheskii Arkhiv|December 21, 2017
[Hepatitis C can be cured: will hepatitis B become next?]V P Chulanov, A P Zueva, D S Kostyushev, et al.
Terapevticheskii Arkhiv|January 18, 2014
[The relevance and prospects of introducing a uniform federal register of patients with viral hepatitis B and C in Russia]N N Pimenov, A V Vdovin, S V Komarova, et al.
Terapevticheskii Arkhiv|January 30, 2016
[Chronic hepatitis C in Russia: current challenges and prospects]V P Chulanov, N N Pimenov, N A Mamonova, et al.
Pageof 4